Base Editing of HBG1 and HBG2 Promoters for Sickle Cell Disease

Journal:

The New England Journal of Medicine

Published:

2026-04-02

DOI:

10.1056/nejmoa2504835

Affiliations:

17

Authors:

26

Go to article

Institutions	Authors	Share
Beam Therapeutics, United States of America (USA)	11.000000 11.000000	0.42
Rainbow Babies & Children's Hospital, United States of America (USA)	1.000000	0.04
Hackensack University Medical Center (Hackensack UMC), United States of America (USA)	1.000000	0.04
University of Miami (UM), United States of America (USA)	1.000000	0.04
The University of Alabama at Birmingham (UAB), United States of America (USA)	1.000000	0.04
Medical College of Wisconsin (MCW), United States of America (USA)	1.000000	0.04
Henry Ford Health System (HFHS), United States of America (USA)	1.000000	0.04
University of Minnesota (UMN), United States of America (USA)	1.000000	0.04
Children's Hospital of Philadelphia (CHOP), United States of America (USA)	1.000000	0.04
Dana-Farber/Boston Children's Cancer and Blood Disorders Center, United States of America (USA)	1.000000	0.04
St. Jude Children's Research Hospital (St. Jude), United States of America (USA)	1.000000	0.04
Mayo Clinic's Campus in Florida, United States of America (USA)	1.000000	0.04
Washington University in St. Louis (WUSTL), United States of America (USA)	1.000000	0.04
Medical University of South Carolina (MUSC), United States of America (USA)	1.000000	0.04
Columbia University Irving Medical Center (CUIMC), CU, United States of America (USA)	1.000000	0.04
TriStar Centennial Medical Center, United States of America (USA)	0.500000	0.02
Sarah Cannon Research Institute (SCRI), United States of America (USA)	0.500000	0.02

Interested in Oncology and Carcinogenesis?